Biological Products, Except Diagnostic Substances (Biotech) - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Biological industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Biological Products, Except Diagnostic Substances (Biotech) - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Biological Products, Except Diagnostic Substances (Biotech)
Corporate Insider Buy Sell Ratio (Insider Count) - Biological Products, Except Diagnostic Substances (Biotech)
Biological Products, Except Diagnostic Substances (Biotech) - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-09-09 INKT / MiNK Therapeutics, Inc. 4 Buell Jennifer A - Award D 15.36 18,229
2025-09-08 TWST / Twist Bioscience Corporation 4 Cho Dennis S - Sale D 25.76 -269
2025-09-08 IPSC / Century Therapeutics, Inc. 4 Russotti Gregory S - Sale D 0.500 -539
2025-09-08 TWST / Twist Bioscience Corporation 4 WERNER ROBERT F. S - Sale D 25.76 -235
2025-09-08 TWST / Twist Bioscience Corporation 4 Leproust Emily M. S - Sale D 25.76 -2,265
2025-09-08 IPSC / Century Therapeutics, Inc. 4 Pfeiffenberger Brent S - Sale D 0.500 -488
2025-09-08 TWST / Twist Bioscience Corporation 4 Green Paula S - Sale D 25.76 -892
2025-09-08 IPSC / Century Therapeutics, Inc. 4 Carr Douglas S - Sale D 0.500 -263
2025-09-08 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 1.9897 -464,421
2025-09-08 TARS / Tarsus Pharmaceuticals, Inc. 4 LINK WILLIAM J PHD S - Sale D 57 -27,116
2025-09-08 PCVX / Vaxcyte, Inc. 4 Cowan Elvia F - Taxes D 32.41 -482
2025-09-08 PCVX / Vaxcyte, Inc. 4 GUGGENHIME ANDREW F - Taxes D 32.41 -2,890
2025-09-08 PCVX / Vaxcyte, Inc. 4 PICKERING GRANT F - Taxes D 32.41 -7,356
2025-09-08 PCVX / Vaxcyte, Inc. 4 Wassil Jim F - Taxes D 32.41 -2,759
2025-09-08 PCVX / Vaxcyte, Inc. 4 Dhaliwal Harpreet S. F - Taxes D 32.41 -1,204
2025-09-07 PCVX / Vaxcyte, Inc. 4 Cowan Elvia A - Award D 2,810
2025-09-05 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 1.9682 -400,000
2025-09-05 CGON / CG Oncology, Inc. 4 Mulay James S - Sale D 31.42 -4,095
2025-09-05 CGON / CG Oncology, Inc. 4 Mulay James S - Sale D 33.22 -3,113
2025-09-05 CGON / CG Oncology, Inc. 4 Mulay James S - Sale D 32.64 -7,465
2025-09-05 CGON / CG Oncology, Inc. 4 Mulay James S - Sale D 30.47 -12,342
2025-09-05 CGON / CG Oncology, Inc. 4 Mulay James M - Exercise D 0.6 27,015
2025-09-05 TRML / Tourmaline Bio, Inc. 4 KANTOFF AARON M - Exercise D 0.13 37,890
2025-09-05 TRML / Tourmaline Bio, Inc. 4 KANTOFF AARON M - Exercise D 9.46 10,000
2025-09-05 FENC / Fennec Pharmaceuticals Inc. 4 Raykov Rosty M - Exercise D 2.45 36,207
2025-09-05 AGEN / Agenus Inc. 4 ARMEN GARO H A - Award D 4.33 3,778
2025-09-04 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 1.9285 -453,016
2025-09-04 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 75.224 -2,300
2025-09-04 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 74.327 -7,800
2025-09-04 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 73.536 -9,900
2025-09-04 FENC / Fennec Pharmaceuticals Inc. 4 Raykov Rosty S - Sale D 8.92 -10,000
2025-09-04 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen M - Exercise D 8.11 20,000
2025-09-03 CGON / CG Oncology, Inc. 4 Song Hong Fang By Chaming Jade Limited S - Sale I 27.6 -69,695
2025-09-03 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 74.22 -9,500
2025-09-03 CGON / CG Oncology, Inc. 4 Song Hong Fang By Charming Jade Limited S - Sale I 28.24 -30,105
2025-09-03 CGON / CG Oncology, Inc. 4 Song Hong Fang By Charming Jade Limited S - Sale I 28.99 -100
2025-09-03 APGE / Apogee Therapeutics, Inc. 4 Dambkowski Carl S - Sale D 38.55 -190
2025-09-03 CGON / CG Oncology, Inc. 4 POST LEONARD E S - Sale D 28 -1,000
2025-09-03 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen S - Sale D 74.632 -10,500
2025-09-03 EDIT / Editas Medicine, Inc. 4 O'Neill Gilmore Neil S - Sale D 2.5961 -5,592
2025-09-03 APGE / Apogee Therapeutics, Inc. 4 Dambkowski Carl S - Sale D 37.82 -2,535
2025-09-03 EDIT / Editas Medicine, Inc. 4 Burkly Linda S - Sale D 2.5961 -710
2025-09-03 EDIT / Editas Medicine, Inc. 4 Parison Amy S - Sale D 2.5961 -458
2025-09-03 RVMD / Revolution Medicines, Inc. 4 Anders Jack S - Sale D 40.1742 -5,238
2025-09-03 VOR / Vor Biopharma Inc. 4 Reprogrammed Interchange LLC S - Sale D 1.9961 -554,612
2025-09-03 CGON / CG Oncology, Inc. 4 Song Hong Fang By Charming Jade Limited S - Sale I 28.96 -100
2025-09-03 RVMD / Revolution Medicines, Inc. 4 Anders Jack M - Exercise D 4.73 3,189
2025-09-03 CGON / CG Oncology, Inc. 4 POST LEONARD E M - Exercise D 0.6 1,000
2025-09-03 RVMD / Revolution Medicines, Inc. 4 Anders Jack M - Exercise D 17 2,049
2025-09-03 HALO / Halozyme Therapeutics, Inc. 4 Torley Helen M - Exercise D 8.11 20,000
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)